CONTROVERSIES IN ADJUVANT ENDOCRINE THERAPY AROMATASE INHIBITORS JAMES F BISHOP MD PROFESSOR OF CANCER MEDICINE, UNIVERSITY OF SYDNEY DIRECTOR, SYDNEY.
